Hillevax Inc (HLVX) Stock Price, Quote & News

Company Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in Febr...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 213 5054

Website: www.hillevax.com

Address:

321 Harrison Avenue, 5th Fl., Boston, United States

CordeliaMoffett824 Sep. 22 at 7:03 AM

$HLVX Biopharmaceutical speculation. Pre-revenue volatility. High risk/reward setup. No pattern.

0 · Reply

TwongStocks Sep. 17 at 1:05 PM

$XOMA closes tender offer for $HLVX https://www.globenewswire.com/news-release/2025/09/17/3151655/7281/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-HilleVax-Inc.html • Following the closing of the tender offer, XOMA acquired HLVX • HLVX shareholders will receive $1.95 and a CVR per share.

0 · Reply

Mergerbrief Sep. 15 at 11:54 AM

$HLVX / $XOMA - Tender Offer Expires MergerBrief.com

0 · Reply

TwongStocks Sep. 12 at 1:47 PM

$HLVX NASDAQ Equity Corporate Actions Alert # 2025 - 503 Information Regarding the Tender Offer of HilleVax, Inc. (HLVX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-503 The tender offer by $XOMA to acquire all of the outstanding common stock of HilleVax, Inc. (HLVX) is scheduled to expire one minute after 11:59 p.m. ET, on September 15, 2025, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on September 17, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on September 16, 2025. If the merger closes as planned, the stock will remain halted on the day of closing (September 17) and will be suspended effective September 18, 2025. Tender offer: HLVX shareholders will receive $1.95 plus one non-transferable contingent value right for each share held. If you own 1000 HLVX, you will receive $1950 plus 1000 CVRs.

0 · Reply

NVDAMillionaire Sep. 10 at 6:37 AM

$HLVX Great piece that accurately captures HLVX's current position. So if you want to refresh your understanding of HLVX or learn about HLVX for the first time, this is essential reading. https://beyondspx.com/quote/HLVX/analysis/hillevax-hlvx-a-strategic-pivot-towards-acquisition-and-contingent-value

0 · Reply

Fastfood123 Sep. 8 at 9:15 PM

$VXRT at one time $HLVX was worth close to 1 billion MC how is it possible they are still worth more than $VXRT this is obvious price suppression/manipulation

0 · Reply

MarketAtlasPoint Aug. 27 at 7:23 AM

$HLVX momentum slowing down, needs strength to push higher.

0 · Reply

TwongStocks Aug. 4 at 12:53 PM

Busy weekend for $XOMA. Closed on two acquisitions. 1) Acquiring $HLVX for $1.95 per share, plus a CVR. CVR payouts as follows: • If HLVX clsoing cash is over $102.95m, CVR holders will receive a pro-rata portion of the remaining cash above that. • 90-100% of any savings from closing of HLVX's Boston office lease obligations. • 90% of any proceeds XOMA receives in the next 5 yearw from the sale or licensing of HLVX's norovirus vaccine program. Sale or license must occur within the next two years. Tender offer expected to close in Sept 2025. 2) Acquiring $LVTX for between $1.16 and $1.24 Per Share in Cash, plus CVR. CVR payout as follows: • 75% of the net proceeds related to LAVA’s two partnered assets • 75% of any net proceeds from any out license or sale of LAVA’s unpartnered programs. Tender offer expected to close in Q4 2025.

0 · Reply

OpenOutcrier Aug. 4 at 12:10 PM

$HLVX (+2.9% pre) $XOMA Royalty to acquire HilleVax for $1.95 per share plus contingent rights https://ooc.bz/l/72366

0 · Reply

DARKP00L Aug. 4 at 11:25 AM

$HLVX 07:25 on Aug. 04 2025 Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times #tradeideas

0 · Reply

HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX

Aug 6, 2025, 4:05 PM EDT - 2 months ago

HilleVax Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 9:20 PM EDT - 2 months ago

HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX

XOMA

Aug 5, 2025, 6:01 PM EDT - 2 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

XOMA

Aug 4, 2025, 8:33 AM EDT - 2 months ago

Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session

KOS

Aug 4, 2025, 7:00 AM EDT - 2 months ago

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

May 8, 2025, 7:00 AM EDT - 5 months ago

HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Apr 17, 2025, 8:00 AM EDT - 6 months ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

PHAT

Mar 28, 2025, 5:00 PM EDT - 6 months ago

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

Aug 8, 2024, 7:20 PM EDT - 1 year ago

HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Jul 30, 2024, 9:00 AM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Jul 29, 2024, 3:30 PM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Urged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

Jul 26, 2024, 3:15 PM EDT - 1 year ago

Stakeholders Of Hillevax Inc Are Encouraged By The Schall Law Firm To Join The Alleged Securities Fraud Investigation

Jul 19, 2024, 3:15 PM EDT - 1 year ago

Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation

Jul 19, 2024, 11:00 AM EDT - 1 year ago

HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Jul 18, 2024, 3:30 PM EDT - 1 year ago

HLVX Investors Are Invited By The Schall Law Firm To Join Its Investigation Into Alleged Securities Fraud At HilleVax Inc.

Jul 17, 2024, 2:15 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Investors To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

Jul 16, 2024, 1:45 PM EDT - 1 year ago

HLVX Investors Are Welcomed By The Schall Law Firm To Join Its Inquiry Into Suspected Securities Fraud At HilleVax Inc

Jul 15, 2024, 2:15 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Of Alleged Securities Fraud At HilleVax Inc

Jul 13, 2024, 5:00 PM EDT - 1 year ago

The Schall Law Firm Encourages HLVX Stakeholders To Join Its Probe Into Suspected Securities Fraud At HilleVax Inc

Jul 12, 2024, 5:40 PM EDT - 1 year ago

The Schall Law Firm Invites HLVX Stakeholders To Participate In Its Investigation Into Alleged Securities Fraud At HilleVax Inc

Jul 11, 2024, 1:00 PM EDT - 1 year ago

Stakeholders Of HLVX Are Urged To Join The Schall Law Firm's Investigation Of Securities Fraud At HilleVax Inc

CordeliaMoffett824 Sep. 22 at 7:03 AM

$HLVX Biopharmaceutical speculation. Pre-revenue volatility. High risk/reward setup. No pattern.

0 · Reply

TwongStocks Sep. 17 at 1:05 PM

0 · Reply

Mergerbrief Sep. 15 at 11:54 AM

$HLVX / $XOMA - Tender Offer Expires MergerBrief.com

0 · Reply

TwongStocks Sep. 12 at 1:47 PM

0 · Reply

NVDAMillionaire Sep. 10 at 6:37 AM

0 · Reply

Fastfood123 Sep. 8 at 9:15 PM

$VXRT at one time $HLVX was worth close to 1 billion MC how is it possible they are still worth more than $VXRT this is obvious price suppression/manipulation

0 · Reply

MarketAtlasPoint Aug. 27 at 7:23 AM

$HLVX momentum slowing down, needs strength to push higher.

0 · Reply

TwongStocks Aug. 4 at 12:53 PM

0 · Reply

OpenOutcrier Aug. 4 at 12:10 PM

$HLVX (+2.9% pre) $XOMA Royalty to acquire HilleVax for $1.95 per share plus contingent rights https://ooc.bz/l/72366

0 · Reply

DARKP00L Aug. 4 at 11:25 AM

$HLVX 07:25 on Aug. 04 2025 Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times #tradeideas

0 · Reply

Trubach Aug. 4 at 11:17 AM

$HLVX

0 · Reply

ZorTrades Jul. 29 at 5:39 PM

🚨 Fresh 13G/13D Filings – Smart Money Moves: 📈 $CTNM – Contineum Therapeutics RA Capital: Top-tier biotech VC/hedge fund led by Peter Kolchinsky, focused on early-to-mid stage healthcare. 🧬 New 2.12M share stake (9.9% of float) — 100% new 📈 $HLVX – HilleVax EcoR1 Capital: Biotech specialist hedge fund run by Oleg Nodelman, known for early innovation bets. 💉 New 2.89M share stake (5.8% of float) — 100% new 📈 $ELBM – Electra Battery Materials Highbridge Capital: Multi-strategy hedge fund founded by Scott Kapnick (ex-Goldman), active in distressed and special sits. 🔋 New 3.59M share stake (9.9% of float) — 100% new All filed late July 2025.

1 · Reply

mikedumbledar Jul. 21 at 2:09 PM

$HLVX this is one of the major problems in the biotech industry. management in biotech sector is really poor and investors don’t trust them to follow their fiduciary responsibility $XBI

0 · Reply

Suh420 Jul. 19 at 12:33 AM

$NWBO look at $HLVX breakout peeps. The setup is clean and we are pressing it soon!

1 · Reply

Suh420 Jul. 19 at 12:31 AM

$GOVX is crap. Look at $HLVX chart and fundamentals. The breakout setup is 10x cleaner and waay better % gain potential. Plus no dilution risk or cash raise need

0 · Reply

Suh420 Jul. 19 at 12:28 AM

$LITS is $HLVX little brother. Big strategic alternative move coming here in this micro cap with over $150MILLION cash and a less than >10mil float. Massive Multi Month Breakout level

0 · Reply

warpdrive1 Jun. 4 at 2:09 PM

$HLVX strategic alternatives incoming

0 · Reply

WAYWARD_SUN May. 19 at 2:41 PM

$HLVX

0 · Reply

joe77w May. 8 at 1:19 PM

$HLVX 10Q out 3 usd in net equity https://www.otcmarkets.com/filing/html?id=18445085&guid=eeV-kFzAdOPedth

0 · Reply

PenkeTrading May. 1 at 12:48 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Hillevax Inc. Is that bullish or bearish? $HLVX #Hillevax #RsiOverbought #NASDAQ

0 · Reply

JarvisFlow Mar. 31 at 11:00 AM

HC Wainwright & Co. has updated their rating for HilleVax ( $HLVX ) to Neutral with a price target of 2.

0 · Reply

d_risk Mar. 30 at 5:22 PM

$HLVX - HilleVax Inc. Common Stock - 10K - Updated Risk Factors HLVX's 2025 10-K Risk Factors highlight a strategic pivot from HIL-214 to broader norovirus vaccine candidates, emphasizing regulatory, patent, and commercialization challenges, workforce reductions, and increased reliance on third-party collaborations. New risks include potential Nasdaq delisting and geopolitical impacts on trade. #Biotechnology #GeopoliticalFactors #MarketCompetition #RegulatoryRisks #VaccineDevelopment 🟢 Added 🟠 Removed https://d-risk.ai/HLVX/10-K/2025-03-28

0 · Reply

Market Cap	104.80M
Revenue (ttm)	0.00
Net Income (ttm)	-147.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,800,100
Avg Vol	747,794
Day's Range	N/A - N/A
Shares Out	50.14M
Stochastic %K	50%
Beta	0.77
Analysts	Hold
Price Target	$1.85